EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program

Lea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, Horst V Bernuth, Kai Lehmberg, Peter Bader, Ulrich Baumann, Rita Beier, Stephan Borte, Inken Brockow, E Graham Davies, Maximilian Hartmann und 21 weitere

Journal of Clinical Immunology · 14.03.2026 · 46 (1)

DOI: 10.1007/s10875-026-01995-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 14.03.2026. Verfasst von Lea Graafen und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Oncology, Haematology and Clinical Immunology, Medical Faculty, Heinrich-Heine- University, University Hospital Düsseldorf, …. Hauptthemen laut MEDLINE: Neonatal Screening, Primary Immunodeficiency Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TREC-NBS identifies patients with inborn errors of immunity (IEI) and syndromic features, but uncertainty remains regarding their immunological management. To address this, syndromic patients detected by TREC-NBS in Germany between August 2019 and April 2024 were systematically analyzed, including phenotype, treatment, and outcomes. National registries were screened, and data were completed by the treating centres. A total of 77 syndromic patients were identified, with 22 different gene defects found in 72 individuals (93.5%). Primary thymic deficiency was present in 64% (49/77), most commonly due to 22q11.2 deletion syndrome (62%). Common clinical features included congenital heart disease (57%), facial/skeletal abnormalities (53%), and neurological symptoms (36%). Definitive treatments were provided promptly in eligible patients, including 6 thymus transplants and 6 hematopoietic stem cell transplants (HSCT). A watch-and-wait approach was applied to the remaining patients, with 34% (22/65) receiving prophylactic treatment. Recovery of CD3 + T-cell counts was limited to a minority. Overall survival was 89%, with a median follow-up of 32 months (range 0.5–60). To conclude, this is the first comprehensive study of syndromic IEI patients identified through TREC-NBS. The findings show that the German healthcare system enables both early prophylactic care and timely access to definitive therapies. Moving forward, interdisciplinary collaboration will be key to developing evidence-based management guidelines for this challenging patient group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningPrimary Immunodeficiency DiseasesHumansGermanyFemaleMaleInfant, NewbornHematopoietic Stem Cell TransplantationChild, PreschoolInfantPhenotypeChildRegistriesT-Lymphocytes

Stichwörter der Autor:innen

Newborn screeningSCIDSyndromic inborn errors of immunityT-cell lymphocytopeniaT-cell receptor excision circlesThymic deficiency

Autor:innen und Institutionen

  • Department of Paediatric Oncology, Haematology and Clinical Immunology, Medical Faculty, Heinrich-Heine- University, University Hospital Düsseldorf, Moorenstraße 5, Düsseldorf, 40225, Germany.
  • Institute for Immunodeficiency, Centre for Chronic Immunodeficiency (CCI), Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany.
  • Department of Paediatric Haematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, Children's Hospital, University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt Am Main, Germany.
  • Department of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institu…
  • Labor Berlin Charité -Vivantes, Department of Immunology, Berlin, Germany.

Förderung

  • Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts

Zitieren

APA

Graafen, L., Speckmann, C., Bakhtiar, S., Bernuth, H. V., Lehmberg, K., Bader, P., Baumann, U., Beier, R., Borte, S., Brockow, I., Davies, E. G., Hartmann, M., Holzer, U., Klemann, C., Kreins, A. Y., Krüger, R., Kontny, U., Laws, H. J., Meinhardt, A., …, & Ghosh, S. (2026). Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-01995-2

Vancouver

Graafen L, Speckmann C, Bakhtiar S, Bernuth HV, Lehmberg K, Bader P, et al. Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-01995-2

BibTeX
@article{Graafen2026,
  author = {Graafen, Lea and Speckmann, Carsten and Bakhtiar, Shahrzad and Bernuth, Horst V and Lehmberg, Kai and Bader, Peter and Baumann, Ulrich and Beier, Rita and Borte, Stephan and Brockow, Inken and Davies, E Graham and Hartmann, Maximilian and Holzer, Ursula and Klemann, Christian and Kreins, Alexandra Y and Krüger, Renate and Kontny, Udo and Laws, Hans-Jürgen and Meinhardt, Andrea and Morbach, Henner and Naumann-Bartsch, Nora and Rothoeft, Tobias and Schneider, Dominik T and Willasch, Andre and Worth, Austen and Seidel, Markus G and Albert, Michael H and Ehl, Stephan and Hauck, Fabian and Hönig, Manfred and Schulz, Ansgar and Schuetz, Catharina and Ghosh, Sujal},
  title = {Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10875-026-01995-2}
}
Kostenlos starten →